OpenVSafe by OpenVAERS
Search V-safe

FRL-17486-38307

3 vaccinations 12 coded responses 34 check-ins 12 free-text entries 0 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
956 / CA
Registered
2021-02-03
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-30
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-03
    Registered in v-safe
  3. 2021-02-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · None
    Adult check-in
  4. 2021-02-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hyperhidrosis, Injection site pain — Feeling: Fair · Nausea · Be unable to do your normal daily activities
    Free text: I had soreness at injection site and sweats for 2-3 days after the shot.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-02-05
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pre-existing disease — Feeling: Good
    Free text: I have COPD diagnosed in 2018
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-02-07
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-13
    Survey response — day 14, dose 1
    MedDRA: Condition aggravated, Dyspnoea, Pre-existing disease — Feeling: Good
    Free text: I have chronic bronchitis. I have what seems like a moderate flare up of breathlessness. No other symptoms of illness.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-20
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  9. 2021-02-23
    Dose 2 — Pfizer-BioNTech
  10. 2021-02-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Nausea
    Adult check-in
  11. 2021-02-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  12. 2021-02-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Adult check-in
  13. 2021-02-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Nausea
    Adult check-in
  14. 2021-02-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyspnoea — Feeling: Good
    Free text: Shortness of breath starting a few weeks ago and persists.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyspnoea — Feeling: Fair
    Free text: Shortness of breath
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-03-02
    Survey response — day 7, dose 2
    MedDRA: Dyspnoea — Feeling: Good · Nausea
    Free text: Shortness of breath.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-10
    Survey response — day 14, dose 2
    MedDRA: Dyspnoea, Respiratory tract congestion — Feeling: Good
    Free text: Have been very congested and having shortness of breath for a few weeks. Dont know if COPD is exacerbated
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-03-16
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-23
    Survey response — day 28, dose 2
    MedDRA: Dyspnoea — Feeling: Fair
    Free text: Breathlessness.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-03-30
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-06
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-25
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-08-24
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-09-27
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  25. 2021-09-29
    Survey response — days 1–6 daily, dose 3
    MedDRA: Body temperature increased — Feeling: Poor · Site: Pain · Muscle or body aches, Nausea · Be unable to do your normal daily activities
    Free text: Temperature up to 99.3 degrees F for 4 hours or so.
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-09-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  27. 2021-10-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  29. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  30. 2021-10-04
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  31. 2021-10-11
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-10-18
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-10-25
    Survey response — day 28, dose 3
    MedDRA: Amnesia — Feeling: Good · Be unable to do your normal daily activities
    Free text: Memory loss.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-11-01
    Survey response — day 35, dose 3
    MedDRA: Amnesia — Feeling: Good · Be unable to do your normal daily activities
    Free text: Short term memory loss, intermittent.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2021-11-08
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-12-27
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  37. 2022-03-28
    Survey response — 6 months, dose 3
    MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activities
    Free text: CoVid infection: Omicron, 12/26/21-1/6/22.
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-09-29
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-30Pfizer-BioNTech
22021-02-23Pfizer-BioNTech
32021-09-27Pfizer-BioNTech Flu

Free text

Release 3 — days 1–6 daily, dose 1

2021-02-04

Systemic reaction (other): I had soreness at injection site and sweats for 2-3 days after the shot.

2021-02-05

Systemic reaction (other): I have COPD diagnosed in 2018

Release 4 — day 14, dose 1

2021-02-13

Symptoms: I have chronic bronchitis. I have what seems like a moderate flare up of breathlessness. No other symptoms of illness.

Release 4 — days 1–6 daily, dose 2

2021-02-28

Systemic reaction (other): Shortness of breath starting a few weeks ago and persists.

2021-03-01

Systemic reaction (other): Shortness of breath

Release 4 — day 7, dose 2

2021-03-02

Systemic reaction (other): Shortness of breath.

Release 5 — day 14, dose 2

2021-03-10

Symptoms: Have been very congested and having shortness of breath for a few weeks. Dont know if COPD is exacerbated

Release 6 — day 28, dose 2

2021-03-23

Symptoms: Breathlessness.

Release 9 — days 1–6 daily, dose 3

2021-09-29

Systemic reaction (other): Temperature up to 99.3 degrees F for 4 hours or so.

Release 10 — day 28, dose 3

2021-10-25

Symptoms: Memory loss.

Release 10 — day 35, dose 3

2021-11-01

Symptoms: Short term memory loss, intermittent.

Release 11 — 6 months, dose 3

2022-03-28

Symptoms: CoVid infection: Omicron, 12/26/21-1/6/22.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAmnesia · · ✓
SDCondition aggravated ✓ ✓ ✓
SDCOVID-19 · · ✓
SDDyspnoea ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDRespiratory tract congestion ✓ ✓ ✓
SROBody temperature increased · · ✓
SRODyspnoea ✓ ✓ ✓
SROHyperhidrosis ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release